Sectors

Great managers can make all the difference to your career and your day to day experience at work. At ICON, our managers play an important role in supporting people to grow, share their expertise and build confidence in ...

Europe is emerging as an attractive route to global market access for Chinese sponsors. Early consideration of EMA requirements can help avoid costly delays and improve approval success. Read the article: https://ow.ly...

Every successful clinical trial starts long before the first participant is enrolled. Site Selection and Activation is one of the most important, yet often overlooked, stages of clinical research. From identifying the r...

The EU's Packaging and Packaging Waste Regulation (PPWR) is set to transform how medical device packaging is managed across Europe. While some contact-sensitive packaging benefits from targeted exemptions, medical devic...

Preparing for Italy's new serialisation framework requires more than regulatory awareness. Marketing authorisation holders, manufacturers and supply chain partners will need to assess packaging configurations, validate ...

Regulatory pathways for biosimilars are changing, with reduced clinical requirements placing greater emphasis on analytical comparability and manufacturing excellence. Understanding how to respond to these shifts can mak...

As biologics, biomarker-enriched trials and real-world evidence reshape the COPD landscape, sponsors face both new opportunities and increasing complexity. Success depends on translating these advances into effective cli...

As biotech confidence returns and deal activity accelerates, companies have an opportunity to position themselves for the next phase of growth. In a new BioPharma Dive article, Deepali Suri, President of ICON Biotech, s...

We are proud to share that ICON has been named a Winner for Organisational Excellence for the second year running at the GCC India Workplace Innovation Summit & Awards 2026. This recognition celebrates organisations red...

Sustainability remains central to how we operate, innovate and support our communities at ICON. Being named in TIME’s World’s Most Sustainable Companies 2026 for a second year underscores our ICON Cares’ focus on respon...

Vaccines save millions of lives each year and help protect communities from preventable diseases. In support of National Immunisation Awareness Month, ICON is proud to have participated in 147 vaccine studies across key ...

Policy binders aren't enough to protect patients on neurologic monoclonal antibodies (mAbs). Clinical practices must embed automated safety rules, like therapy holds for active infections, directly into EHR systems. Disc...